calendar
28,966 catalysts · 9,438 approval · 5,000 device 510k · 4,728 grant · 3,009 8k filing · 2,000 device pma · 2,000 device recall
28,966 catalysts · 9,438 approval · 5,000 device 510k · 4,728 grant · 3,009 8k filing · 2,000 device pma · 2,000 device recall
Sponsor: ROSEMONT. Form: SOLUTION. Route: ORAL
Sponsor: CIPHER PHARMS INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: STRIDES PHARMA INTL. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: SPECGX LLC. Form: CONCENTRATE. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: GENUS. Form: SYRUP. Route: ORAL
Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: ALKEM LABS LTD. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ALKEM LABS LTD. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTABLE. Route: INJECTION
Sponsor: EXELIXIS INC. Form: TABLET. Route: ORAL
Sponsor: SEAGEN. Form: INJECTABLE. Route: INJECTION
Sponsor: UPSHER SMITH LABS. Form: CAPSULE. Route: ORAL
Sponsor: SUN PHARMA CANADA. Form: SOLUTION. Route: ORAL
Sponsor: INDIVIOR. Form: SOLUTION, EXTENDED RELEASE. Route: SUBCUTANEOUS
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: SECURA. Form: CAPSULE. Route: ORAL
Sponsor: DEXCEL. Form: TABLET. Route: ORAL
Sponsor: Lundbeck Seattle BioPharmaceuticals, Inc.. Form: INJECTABLE. Route: INJECTION
Sponsor: ABBVIE. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: FOR SOLUTION. Route: ORAL
Sponsor: SPROUT PHARMS. Form: TABLET. Route: ORAL
Sponsor: ELI LILLY AND CO. Form: INJECTABLE. Route: INJECTION
Sponsor: PHARMAAND. Form: TABLET. Route: ORAL
Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVO NORDISK INC. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: NOVO NORDISK INC. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: ABBVIE. Form: TABLET. Route: ORAL
Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INJECTION
Sponsor: ACTAVIS LABS FL. Form: CAPSULE. Route: ORAL
Sponsor: UPSHER SMITH LABS. Form: CAPSULE. Route: ORAL
Sponsor: TEVA PHARMS USA. Form: CAPSULE. Route: ORAL
Sponsor: UPSHER SMITH LABS. Form: CAPSULE. Route: ORAL
Sponsor: SUN PHARM INDS INC. Form: CAPSULE. Route: ORAL
Sponsor: MYLAN PHARMS INC. Form: CAPSULE. Route: ORAL
Sponsor: TEVA PHARMS USA. Form: CAPSULE. Route: ORAL
Sponsor: SUN PHARM. Form: CAPSULE. Route: ORAL
Sponsor: UPSHER SMITH LABS. Form: CAPSULE. Route: ORAL
Sponsor: AMNEAL PHARMS NY. Form: CAPSULE. Route: ORAL
Sponsor: DR REDDYS LABS LTD. Form: CAPSULE. Route: ORAL
Sponsor: WATSON LABS TEVA. Form: CAPSULE. Route: ORAL
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL
Sponsor: PF PRISM CV. Form: POWDER. Route: INTRAVENOUS
Sponsor: PF PRISM CV. Form: FOR SUSPENSION. Route: ORAL
Sponsor: EUGIA PHARMA. Form: INJECTABLE. Route: INJECTION
Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INJECTION